4th Quarter - Report

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for ASSOCIATION FOR MOLECULAR PATHOLOGY

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
MICHAELA C HOLLIS —
JENNIFER RACHEL LEIB —
ERIKA MILLER Intern, Rep. Steve Rothman
STEFANIE CLAUDETTE WINSTON RINEHART —
LINDSEY TRISCHLER New —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 3635 (115th)

Medical/Disease Research/Clinical Labs MED

Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act HR 5062, Advancing Access to Precision Medicine Act No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB —
LINDSEY TRISCHLER —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 5062 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.